A352940 Stock Overview
Enbio Co., Ltd. produces and sells pesticides in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ENBIO Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,330.00 |
| 52 Week High | ₩6,490.00 |
| 52 Week Low | ₩2,145.00 |
| Beta | 0.94 |
| 11 Month Change | 3.10% |
| 3 Month Change | -11.07% |
| 1 Year Change | -38.36% |
| 33 Year Change | -71.79% |
| 5 Year Change | n/a |
| Change since IPO | -80.90% |
Recent News & Updates
Shareholder Returns
| A352940 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | 3.1% | -5.7% | -0.5% |
| 1Y | -38.4% | -15.6% | 7.3% |
Return vs Industry: A352940 underperformed the KR Chemicals industry which returned -15.6% over the past year.
Return vs Market: A352940 underperformed the KR Market which returned 7.3% over the past year.
Price Volatility
| A352940 volatility | |
|---|---|
| A352940 Average Weekly Movement | 4.2% |
| Chemicals Industry Average Movement | 6.3% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in KR Market | 12.2% |
| 10% least volatile stocks in KR Market | 3.6% |
Stable Share Price: A352940 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A352940's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | M.J. Lee | www.enbio.co.kr |
Enbio Co., Ltd. produces and sells pesticides in South Korea. It offers fungi-insecticides, fungicides, insecticides, herbicides, plant growth regulars, and fertilizers. The company was founded in 1997 and is headquartered in Gunpo, South Korea.
ENBIO Co., Ltd. Fundamentals Summary
| A352940 fundamental statistics | |
|---|---|
| Market cap | ₩25.32b |
| Earnings (TTM) | -₩4.26b |
| Revenue (TTM) | ₩33.51b |
0.8x
P/S Ratio-5.9x
P/E RatioIs A352940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A352940 income statement (TTM) | |
|---|---|
| Revenue | ₩33.51b |
| Cost of Revenue | ₩26.01b |
| Gross Profit | ₩7.50b |
| Other Expenses | ₩11.76b |
| Earnings | -₩4.26b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -392.13 |
| Gross Margin | 22.37% |
| Net Profit Margin | -12.72% |
| Debt/Equity Ratio | 37.4% |
How did A352940 perform over the long term?
See historical performance and comparison